글로벌 티로신 키나제 억제제 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 티로신 키나제 억제제 시장

티로신 키나제 억제제 시장은 2021년에서 2028년까지의 예측 기간 동안 5.9%의 시장 성장을 목격할 것으로 예상됩니다. 티로신 키나제 억제제 시장에 대한 Data Bridge Market Research 보고서는 예측 기간 내내 만연할 것으로 예상되는 다양한 요인에 대한 분석과 통찰력을 제공하고 시장 성장에 미치는 영향을 제공합니다. 전 세계적으로 의료 분야의 급속한 발전은 티로신 키나제 억제제 시장의 성장을 가속화하고 있습니다.

티로신 키나제 억제제는 티로신 키나제라는 단백질을 억제하는 약물 유형을 말합니다. 이 단백질은 세포 신호 전달, 성장 및 분열과 같은 세포 기능을 주로 담당하는 신호 전달 카스케이드를 활성화하는 효소로 정의됩니다. 이 효소의 비정상적인 형성과 방출은 암의 성장을 촉진합니다.

전 세계적으로 암 발병률이 증가하는 것은 티로신 키나제 억제제 시장 성장을 견인하는 주요 요인 중 하나입니다. 경구 투여의 용이성, 여러 세포 생존 경로를 표적으로 삼을 수 있는 능력과 같은 장점으로 인해 기존 치료법에 비해 티로신 키나제 억제제 채택이 증가하고 혁신적인 치료법에 대한 수요가 증가하면서 시장 성장이 가속화됩니다. 제약 회사의 투자 증가와 암에서 다양한 세포 활동을 조절하는 데 세포 프로세스를 사용하면 시장에 더 많은 영향을 미칩니다. 또한 의료비 지출 증가, 인지도 증가, 인구 증가, 개선된 의료 인프라 및 암 치료의 발전은 티로신 키나제 억제제 시장에 긍정적인 영향을 미칩니다. 나아가 새로운 치료법과 여러 혁신, 고급 치료법에 대한 수요 증가는 2021년에서 2028년 사이의 예측 기간 동안 시장 참여자에게 수익성 있는 기회를 확대합니다.

On the other hand, high costs associated with development and drug post-approval, and stringent regulations are expected to obstruct the market growth. Side effects associated with tyrosine kinase inhibitor drugs such as fatigue, muscle cramps, vomiting among others, and lack of technical professionals are projected to challenge the tyrosine kinase inhibitors market in the forecast period of 2021-2028.

This tyrosine kinase inhibitors market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on tyrosine kinase inhibitors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Global Tyrosine Kinase Inhibitors Market Scope and Market Size

The tyrosine kinase inhibitors market is segmented on the basis of type, application, end users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications. 

• On the basis of type, the tyrosine kinase inhibitors market is segmented into BCR-ABL tyrosine kinase inhibitor, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors, vascular endothelial growth factor (VEGFR) tyrosine kinase inhibitors and others.
• On the basis of application, the tyrosine kinase inhibitors market is segmented into chronic myeloid leukemia (CML), lung cancer, breast cancer and others.
• On the basis of end users, the tyrosine kinase inhibitors market is segmented into hospitals, homecare, specialty clinics and others.
• On the basis of distribution channel, the tyrosine kinase inhibitors market is segmented into hospital pharmacy, online pharmacy, retail pharmacy and others.

Tyrosine Kinase Inhibitors Market Country Level Analysis

The tyrosine kinase inhibitors market is analyzed and market size insights and trends are provided by country, type, application, end users and distribution channel as referenced above.      

The countries covered in the tyrosine kinase inhibitors market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the tyrosine kinase inhibitors market because of the developed and well-structured health care system within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2021 to 2028 due to the large population and high prevalence of cancer in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The tyrosine kinase inhibitors market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Tyrosine Kinase Inhibitors Market Share Analysis

The tyrosine kinase inhibitors market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to tyrosine kinase inhibitors market.

티로신 키나제 억제제 시장 보고서에서 다루는 주요 기업으로는 F. Hoffmann-La Roche Ltd, Takeda Pharmaceutical Company Limited, Ascentage Pharma, AstraZeneca, Eisai Co., Ltd., Novartis AG, Sanofi, Bristol-Myers Squibb Company, Genentech, Inc., Pfizer Inc., Merck & Co., Inc., Suzhou Zelgen Biopharmaceuticals Co., Ltd., Celldex Therapeutics, Exelixis, Inc., Sino Biological Inc., AB Science, Bayer AG Deciphera Pharmaceuticals, Inc., Johnson & Johnson Services, Inc. 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-50253